A. Muldal - Concepedia

Author

A. Muldal

Ottawa Regional Cancer Foundation

Also Known As

A M Muldal, A MULDAL, A Muldal, A. Muldal, Alison M. Muldal, Alison Muldal

Publications

Citations

H-Index

Concepts

All Affiliations

Ottawa Regional Cancer Foundation Queen's University

About

A. Muldal is an author at Ottawa Regional Cancer Foundation specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	269
2	Immunology	2	2	25
3	Natural Sciences	1	1	57
4	Biology	1	1	57
5	Obstetrics	1	1	13

A. Muldal

Publications

597

Citations

H-Index

Page 1

	Year	Citations
Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group. M E Trudeau, Elizabeth A. Eisenhauer, B P Higgins, Journal of Clinical Oncology	1996	161
Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC) Yvon Cormier, E. Eisenhauer, A. Muldal, Annals of Oncology MedicinePharmacologyActive New AgentAnti-cancer AgentCancer Treatment	1994	146
Parental care of nestlings by male red-winged blackbirds A. Muldal, J. David Moffatt, Raleigh J. Robertson Behavioral Ecology and Sociobiology Breeding BehaviorParental CareEvolutionary BiologyAvian EvolutionAnimal Behavior	1986	80
Gemcitabine in advanced renal cell carcinoma W. C. Mertens, Elizabeth A. Eisenhauer, Malcolm J. Moore, Annals of Oncology UrologyGenitourinary CancerKidney ResearchMedicineOncology	1993	61
Preferred Nest Spacing of an Obligate Cavity-Nesting Bird, the Tree Swallow A. Muldal, H. Lisle Gibbs, Raleigh J. Robertson Ornithological Applications BiologyBreeding BehaviorForagingDifferent SpiralsNatural Sciences	1985	57
Docetaxel in advanced renal carcinoma W. C. Mertens, E. Eisenhauer, Jacques Jolivet, Annals of Oncology UrologyGenitourinary CancerMedicineRenal PathologyAdvanced Renal Carcinoma	1994	37
Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study. Theodore A. Vandenberg, K. Pritchard, E. Eisenhauer, Journal of Clinical Oncology	1993	30
Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma James J. Rusthoven, E. Eisenhauer, J. Mazurka, JNCI Journal of the National Cancer Institute MedicineImmunologyRecurrent Ovarian CarcinomaGynecologyImmune Checkpoint Inhibitor	1993	13
Didemnin B in favourable histology non-Hodgkin's lymphoma Glenwood Goss, A. Muldal, Reinhard Lohmann, Investigational New Drugs Didemnin BLymphoid NeoplasiaHematologyImmunologyPathology	1995	12

Page 1